Blood-Based Biomarkers for Alzheimer’s and Parkinson’s Disease, Volume 191 in the International Review of Neurobiology series, presents current advances and comprehensive reviews on the development and application of circulating biomarkers in neurodegenerative disorders. This volume brings together contributions from an international panel of experts, highlighting emerging strategies for early detection, diagnosis, and monitoring of Alzheimer’s and Parkinson’s diseases. Chapters in this release explore a wide range of biomarker modalities, including exosomes, oxidative stress markers, mitochondrial dysfunction indicators, and astrocyte-associated proteins. Additional contributions examine advances in nanomaterial-based detection systems, proteomic approaches, and biofluid-based biosensors, as well as the role of neurofilament light chain and other circulating markers in clinical applications. Further sections address the integration of biomarkers with disease mechanisms, including vascular contributions, microbiome influences, and metabolic and dietary factors. The volume also discusses challenges and opportunities in translating blood-based biomarkers into clinical practice. Together, these chapters provide a comprehensive overview of the evolving landscape of non-invasive biomarkers, making this volume an essential reference for researchers and clinicians in neuroscience and neurodegenerative disease research.
